Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.
Clinical trial NCT05785390 · TERMINATED
Trial details
- NCT number
- NCT05785390
- Sponsor
- Novatek Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2025-05-09
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.